StockData
ELI LILLY & Co logo

ELI LILLY & Co (LLY) operating KPIs

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)

Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%

Eli Lilly repayments of long-term debt ($M) ($M)

Quarterly figures from Eli Lilly's filings and investor materials

QuarterlyAnnual
Latest, Q2 2026
873
Period ended Jun 30, 2026
Change on a year earlier
+12.2%
778 in Q2 2025
History
64 quarters
Since Q3 2008
Sources
50
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedRepayments of long-term debt ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026873+12.2%Form 10-Q (filed 2026-08-05) ↗
Q1 2026Mar 31, 2026750–Form 10-Q (filed 2026-04-30) ↗
Q4 2025Dec 31, 2025-0.10-50.0%Form 10-K (filed 2026-02-12) ↗
Q3 2025Sep 30, 20250.10–Form 10-Q (filed 2026-08-05) ↗
Q2 2025Jun 30, 2025778–Form 10-Q (filed 2026-08-05) ↗
Q1 2025Mar 31, 2025-0–Form 10-Q (filed 2026-04-30) ↗
Q4 2024Dec 31, 2024-0.20–Form 10-K (filed 2026-02-12) ↗
Q3 2024Sep 30, 2024-0–Form 10-Q (filed 2024-10-30) ↗
Q4 2023Dec 31, 2023-0–Form 10-K (filed 2024-02-21) ↗
Q3 2023Sep 30, 2023-0–Form 10-Q (filed 2023-11-02) ↗
Q2 2023Jun 30, 2023-0-100.0%Form 10-Q (filed 2023-08-08) ↗
Q1 2023Mar 31, 2023-0-100.0%Form 10-Q (filed 2023-04-27) ↗
Q4 2022Dec 31, 2022-0-100.0%Form 10-K (filed 2023-02-22) ↗
Q3 2022Sep 30, 2022-0-100.0%Form 10-Q (filed 2022-11-01) ↗
Q2 2022Jun 30, 2022850–Form 10-Q (filed 2022-08-04) ↗
Q1 2022Mar 31, 2022710–Form 10-Q (filed 2022-04-29) ↗

Cite this data

StockData. (2026). Eli Lilly Repayments of long-term debt ($M) ($M), quarterly Q3 2008–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/fin_debt_rep

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.